Arecor Announces Positive Headline Results for the First Phase I Clinical Trial of AT247, a Novel Ultra Rapid Acting Formulation of Insulin

NEXT STORY
Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics
PREV STORY
Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Provides Final Results on Its Previously Disclosed Research With Ben-Gurion University of the Negev

author_avatar
NASDAQ Market News

Beta-Carotene Market To Reach USD 654.0 Million By 2027 Growing at a CAGR of 3.3% | Reports and Data

author_avatar
NASDAQ Market News

Orphazyme reports positive results from full data set of Phase II/III arimoclomol trial in Niemann-Pick disease Type C (NPC)

Orphazyme A/SCompany announcement                                                                                                                   No. 01/2019                                                                                             ...

author_avatar
NASDAQ Market News